(World Health Organization. Herpes simplex virus. Basic facts, March 22, 2022), https://www.who.int/ru/news-room/fact-sheets/detail/herpes-simplex-virus

2. Gnann J.W., Whitley R.J. Genital Herpes. New Engl. J. Med. 2016; 375(7): 666–74. DOI: 10.1056/nejmcp1603178

3. Suazo P.A., Ibañez F.J., Retamal-Díaz A.R., Paz-Fiblas M.V., Bueno S.M., Kalergis A.M. et al. Evasion of Early Antiviral Responses by Herpes Simplex Viruses. Mediator of inflammation 2015; 1–16. DOI:10.1155/2015/593757

4. Chemaitelly H., Nagelkerke N., Omori R., Abu-Raddad L.J. Characterizing herpes simplex virus type 1 and type 2 seroprevalence declines and epidemiological association in the United States. PloS One 2019; 14(6): e0214151. DOI:10.1371/journal.pone.0214151

5. Sauerbrei A. Genital herpes. Diagnostics to Pathogenomics of Sexually Transmitted Infections. West Sussex: John Wiley & Sons Ltd, 2018. 416 p.

6. Whitley R., Baines J. Clinical management of herpes simplex virus infections: past, present, and future. F1000Research 2018; (7): 1726. DOI:10.12688/f1000research.16157.1

7. Suazo PA, Ibañez FJ, Retamal-Díaz AR, Paz-Fiblas MV, Bueno SM, Kalergis AM, González PA. Evasion of early antiviral responses by herpes simplex viruses. Mediators of inflammation. 2015 Article ID 593757 https://doi.org/10.1155/2015/593757

8. Jaishankar D., Shukla D. Genital herpes: Insights into Sexually Transmitted Infectious Disease. Microbial Cell. 2016; 3(9): 438–50. DOI:10.15698/mic2016.09.528

9. Zhu S., Viejo-Borbolla A. Pathogenesis and virulence of herpes simplex virus. Virulence 2021; 12(1): 2670–702. DOI:10.1080/21505594.2021.1982373

10. Cole S. Herpes simplex virus: epidemiology, diagnosis, and treatment. Nursing Clinics 2020; 55(3): 337–45. DOI:10.1016/j.cnur.2020.05.004

11. Хрянин А.А., Кнорринг Г.Ю. Генитальный герпес: современные представления и перспективы лечения. Гинекология 2020; 22(4): 62–7. DOI: 10.26442/20795696.2020.4.200259

Khryanin A.A., Knorring G.Yu. (Genital herpes: modern views and prospects for the treatment). Gynecology 2020; 22(4): 62–7 (In Russ.). DOI: 10.26442/20795696.2020.4.200259

12. Singh N., Tscharke D.C. Herpes simplex virus latency is noisier the closer we look. J. Virol. 2020; 94(4): е01701–19. DOI:10.1128/JVI.01701-19

13. Harfouche M., Abu-Hijleh F.M., James C., Looker K.J., Laith J. A. Epidemiology of herpes simplex virus type 2 in sub-Saharan Africa: Systematic review, meta-analyses, and meta-regressions. Clin. Med. 2021; 35: 100876. DOI:10.1016/j.eclinm.2021.100876

14. Tan D.N.S., Murphy K., Shah P., Walmsley S.L. Herpes simplex virus type 2 and HIV disease progression: a systematic review of observational studies. BMC Infect. Dis. 2013; 13: 502. DOI:10.1186/1471-2334-13-502

15. Fatahzadeh M., Schwartz R.A. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J. Am. Acad. Dermatol. 2007; 57(5): 737–63. DOI:10.1016/j.jaad.2007.06.027

16. Kreisel K.M., Spicknall I.H., Gargano J.W., Lewis F.M.T., Lewis R.M., Markowitz L.E. et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2018. Sexually Transmitted Diseases 2021; 48(4): 208–14. DOI:10.1097/OLQ.0000000000001355

17. Volpi A., Stanberry L. Genital Herpes: Clinical and Scientific Novelties. Sexually Transmitted Infections: Advances in Understanding and Management 2020; 223–31. DOI:10.1007/978-3-030-02200-6_11

18. Richards J., Krantz E., Selke S., Wald A. Healthcare seeking and sexual behavior among patients with symptomatic newly acquired genital herpes. Sexually Transmitted Diseases 2008; 35(12): 1015–21. DOI:10.1097/OLQ.0b013e318182a596

19. James C., Harfouche M., Welton N.J., Turner K.M., Abu-Raddad L.J., Gottlieb S.L. et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bulletin of the World Health Organization 2020; 98(5): 315–29. DOI:10.2471/BLT.19.237149

20. Phipps W., Saracino M., Magaret A., Selke S., Remington M., Huang M.-L. et al. Persistent genital herpes simplex virus-2 shedding years following the first clinical episode. J. Infect. Dis. 2011; 203(2): 180–7. DOI:10.1093/infdis/jiq035

21. Looker K.J., Magaret A.S., May M.T., Turner K.M.E., Vickerman P., Newman L.M. et al. First estimates of the global and regional incidence of neonatal herpes infection. The Lancet Global Health 2017; 5(3): 300–9. DOI:10.1016/S2214-109X(16)30362-X

22. Hammad W.A.B., Konje J.C. Herpes simplex virus infection in pregnancy – An update. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; 259: 38–45. DOI:10.1016/j.ejogrb.2021.01.055

23. LeGoff J., Péré H., Bélec L. Diagnosis of genital herpes simplex virus infection in the clinical laboratory. Virology Journal. 2014; (11): 83. DOI:10.1186/1743-422X-11-83

24. Nath P., Kabir M.A., Doust S.K., Ray A. Diagnosis of Herpes Simplex Virus: Laboratory and Point-of-Care Techniques. Infectious Disease Reports. 2021; 13(2): 518–39. DOI:10.3390/idr13020049

25. Amudha V.P., Rashetha S.M., Sucilathangam G., Cinthujah B., Revathy C. Serological profile of HSV-2 in STD patients: Evaluation of diagnostic utility of HSV-2 IgM and IgG detection. Journal of Clinical and Diagnostic Research – JCDR 2014; 8(12): 16–9. DOI:10.7860/JCDR/2014/10586.5314

26. Johnston C., Corey L. Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding. Clin. Microbiol. Rev. 2016; 29(1): 149–61. DOI:10.1128/CMR.00043-15

27. Workowski K.A., Bachmann L.H., Chan P.A., Johnston C.M., Muzny C.A., Park I. et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm. Rep. 2021; 70(4): 1–187. DOI:10.15585/mmwr.rr7004a1

28. Johnston C. Diagnosis and Management of Genital Herpes: Key Questions and Review of the Evidence for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines. Clin. Infect. Dis. 2022; 7 (Suppl. 2): 134–43. DOI:10.1093/cid/ciab1056

29. Patel R., Green J., Clarke E, Seneviratne K., Abbt N., Evans C. et al. 2014 UK national guideline for the management of anogenital herpes. International journal of STD & AIDS 2015; 26(11): 763–76. DOI:10.1177/0956462415580512

30. Álvarez D.M., Castillo E., Duarte L.F., Arriagada J., Corrales N., Farías M.A. et al. Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus Infection. Frontiers in Microbiology 2020; (11): 139. DOI:10.3389/fmicb.2020.00139

31. Harris J.B., Holmes A.P. Neonatal Herpes Simplex Viral Infections and Acyclovir: An Update. J. Pediatr. Pharmacol. Ther. 2017; 22(2): 88–93. DOI:10.5863/1551-6776-22.2.88

32. Foley E., Clarke E., Beckett V.A., Harrison S., Pillai A., FitzGerald M. et al. Management of Genital Herpes in Pregnancy Guideline Development Group. 2014. https://www.rcog.org.uk/globalassets/documents/quidelines/ management-genital-herpes.pdf

33. Mujugira A., Magaret A.S., Celum C., Baeten J.M., Lingappa J.R., Morrow R.A. et al. Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial. J. Infect. Dis. 2013; 208(9): 1366–74. DOI:10.1093/infdis/jit333

34. Jiang Yu-C., Feng H., Lin Yu-C., Guo X.-R. New strategies against drug resistance to herpes simplex virus. International journal of oral science 2016; 8(1): 1–6. DOI:10.1038/ijos.2016.3

35. Kotton B.D., Kotton C.N. Resistant herpes simplex virus infections–who, when, and what’s new? Curr. Opin. Infect. Dis. 2022; 35(6): 530–5. DOI:10.1097/QCO.0000000000000889